RE: This is a board about Avacta29 Jan 2021 09:21
Well your far more polite than I am mowzer, patience is wearing thin with these kind of posts.
Gruffell - I cant see what you wrote back but your original post about Hero to Zero.....only in the eyes of an impatient PI who hasn't made their money quick enough.
How about you take a step back and have some perspective on what AVCT is trying to do an the industry it operates in.
It is a small cap biotech company - since COVID it has been catapulted into the lions den with the big boys in the pharma world.
AVCT do not have thousands of staff, endless resource, unlimited R&D cash to throw at this stuff or receive and govt funding. Then look at what they are trying to achieve:
BAMS (on sale for research purposes)
ELISA
LFT (AN and saliva)
AVA6000
Neutralising therapy
Licensing deals for Affimers in various non covid areas (Astrea RNS).
Look who we have on board:
Daewoong
LGChem
Brucker
BBI/Moderna/Cytiva(maybe still)
And you're trying to tell me AS has gone from hero to zero because its later than he naively told us last year, when actually most of the issues have been third party related (bar the focus on Saliva initially)?
Nothing has been shown to not work and this is the biomed industry, delays are inevitable working in a space where it is EXPERIMENTAL. The man has done a great job in spinning all the plates that are going, whilst trying to protect the financials of the business as well as the Affimer IP - (i.e. not chasing a quick Covid buck like Innova did despite some like xxxyyyzzz thinking that was the right thing to do).
People need to cut him a break, take a step back and realise what has been achieved here. The foundations have been laid.